Using PET-MRI imaging for esophagogastric cancer treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the feasibility of incorporating PET-MRI imaging into the radiation treatment workflow for patients with esophagogastric cancer. It involves a single-arm approach where imaging is performed before, during, and after radiation treatment. The goal is to gather data that could enhance future radiation therapy planning and patient care. The study will include up to 15 patients and is conducted at a single center.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients 18 years or older
* Diagnosed with locally advanced esophageal cancer being considered for conventional RT \>4 weeks
* Ability and willingness to provide written informed consent

Exclusion Criteria:

* Contraindication for MRI
* Contraindication for Gadolinium (i.e. inability to lie supine for at least 60 minutes)
* Any patient who is pregnant or breastfeeding
* Pacemaker or implanted defibrillator
* Claustrophobia

Where it's running

• Princess Margaret Cancer Centre
  Toronto, Ontario, Canada Recruiting

Study contacts

• Study coordinator: Rebecca K S Wong, MD
• Email: rebecca.wong@uhn.ca
• Phone: 4169462000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Combination treatment for gastroesophageal junction and esophagogastric cancer

  This study is testing a new combination of liposomal irinotecan with standard treatments to see if it helps people with gastroesophageal junction or esophagogastric cancer feel better.

  Recruiting at 2 sites Phase 2 Massachusetts General Hospital · Boston, Massachusetts and 2 other locations · NCT04656041

• Chemoradiotherapy for esophageal and esophagogastric junction cancer

  This study is testing a new combination of chemotherapy, radiation, and immune therapies to see if it helps people with advanced esophageal or esophagogastric junction cancer live longer and feel better.

  Recruiting at 5 sites Phase 3 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Anyang, Henan and 4 other locations · NCT04821778

• Using MRI and CT to Evaluate Tumor Response in Esophageal Cancer Treatment

  This study tests whether MRI can better track how well treatment is working for people with esophageal cancer compared to regular CT scans.

  Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing · NCT02988921

• Testing a new drug for patients with advanced solid tumors

  This study is testing a new drug called JR8603 to see if it can help people with advanced solid tumors that haven't responded to other treatments.

  Recruiting at 2 sites Phase 1 JiaRay Group · Harbin, Heiljiang Province and 1 other locations · NCT06783569

• Neoadjuvant treatments for esophageal cancer

  This study is testing different combinations of treatments for people with esophageal cancer to see if they can improve outcomes compared to just having surgery.

  Recruiting Phase 3 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing · NCT04821843

• Combining PD-1 inhibitors with chemotherapy for advanced gastric cancer treatment

  This study is testing if combining a new drug with chemotherapy can help people with advanced stomach cancer feel better and live longer.

  Recruiting Fudan University · Shanghai, Shanghai Municipality · NCT06158919

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.